Energy Services of America Corporation has agreed to acquire nearly all operating assets of FAMCO, a West Virginia utility contractor specializing in water and sewer infrastructure, for $6.95 million. The payment will be made partly in cash and partly in Energy Services common stock, with the deal expected to close around October 9, 2026. This acquisition will enhance Energy Services' existing water and utility construction operations by adding FAMCO's experienced workforce, equipment, and customer contracts. The move aims to strengthen the company's capabilities in the water and utility sector in the mid-Atlantic and Central U.S. regions.
Energy Services of America’s acquisition deal is announced as a backdrop to Industrials sector trading on Pluang. For readers following Industrials, here is Pluang's market snapshot as of Oct 02, 2026 02:51 WIB: out of 93 priced US Industrials stocks, 69 rose and 24 fell. Notable movers include SBLK at USD 30.54 with a 4.02% increase and 100% buy order activity, CHRW at USD 153.80 up 3.95% also with 100% buy orders, and ENVX at USD 2.79 down 3.62% with 89% buy orders.
Wells Fargo initiated coverage on BlackRock with an 'Overweight' rating, highlighting it as a good entry point for investors. Analysts expect BlackRock's Q3 earnings per share to rise to $14.25 from $11.55 a year ago, with revenue projected at $7.56 ...
Nike reported earnings per share of $0.48, beating estimates, but revenue fell short at $11.21 billion due to weak demand in Greater China and rising competition. The company issued a cautious fiscal 2027 outlook with EPS forecast between $1.15 and $...
NETSOL Technologies reported a record $20.7 million revenue in fiscal 2026 Q4, with net income rising 45.9% to $3.8 million. The company improved its gross margin to 63.6% and operating margin to 21.6%, reflecting enhanced profitability. For fiscal 2...
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...
Jefferies analyst Roger Song set a $150 price target for Nektar Therapeutics, suggesting a 219% upside from its $46.99 trading price. This comes after Nektar presented positive six-month Phase IIb trial results for its alopecia drug REZPEG, which als...
